Human papillomavirus classification: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 19: Line 19:
|-
|-
| style="padding: 7px 7px; background: #DCDCDC;" |'''Common wart'''
| style="padding: 7px 7px; background: #DCDCDC;" |'''Common wart'''
| style="padding: 7px 7px; background: #F5F5DC;" |1,2
| style="padding: 7px 7px; background: #F5F5DC;" |1, 2, 4
| style="padding: 7px 7px; background: #F5F5DC;" |4, 26, 27, 29, 41, 57, 63, 65, 77, 117, 125, 128, 129, 130, 131, 132, 133, 148, 149
| style="padding: 7px 7px; background: #F5F5DC;" |4, 26, 27, 29, 41, 57, 63, 65, 77, 117, 125, 128, 129, 130, 131, 132, 133, 148, 149
|-
|-
| style="padding: 7px 7px; background: #DCDCDC;" | '''Gonococcal Urethritis'''
| style="padding: 7px 7px; background: #DCDCDC;" |'''Plantar wart'''
| style="padding: 7px 7px; background: #F5F5DC;" |Preferred:
| style="padding: 7px 7px; background: #F5F5DC;" |1, 2
:::::[[Ceftriaxone]] 250 mg IM in a single dose
| style="padding: 7px 7px; background: #F5F5DC;" |26, 27, 29, 41, 57, 63, 65, 77, 117, 125, 128, 129, 130, 131, 132, 133, 148, 149
:::::::::'''PLUS'''
:::::[[Azithromycin]] 1 g PO in a single dose
Alternative:
:::::[[Cefixime]] 400 mg PO in a single dose
:::::::::'''PLUS'''
:::::[[Azithromycin]] 1 g PO in a single dose
|-
|-
| style="padding: 7px 7px; background: #DCDCDC;" | '''Recurrent and Persistent Urethritis'''
| style="padding: 7px 7px; background: #DCDCDC;" | '''Flat and intermediate warts '''
| style="padding: 7px 7px; background: #F5F5DC;" |
| style="padding: 7px 7px; background: #F5F5DC;" |3, 10
:::::[[Metronidazole]] 2 g PO in a single dose
| style="padding: 7px 7px; background: #F5F5DC;" |26, 27, 28, 38, 41, 49, 75, 76, 126
:::::::::''or''
|-
:::::[[Tinidazole]] 2 g PO in a single dose
| style="padding: 7px 7px; background: #DCDCDC;" | '''Common warts of meat, poultry, and fish handlers'''
:::::::::'''PLUS'''
| style="padding: 7px 7px; background: #F5F5DC;" |2, 7
:::::[[Azithromycin]] 1 g PO in a single dose
| style="padding: 7px 7px; background: #F5F5DC;" |1, 3, 4, 10, 28
|-
| style="padding: 7px 7px; background: #DCDCDC;" | '''Epidermodysplasia verruciformis'''
| style="padding: 7px 7px; background: #F5F5DC;" |3, 5, 8
| style="padding: 7px 7px; background: #F5F5DC;" |9 , 12 , 14 , 15 , 17 , 19–25 , 36–38 , 47 , 49 , 50
|-
| style="padding: 7px 7px; background: #DCDCDC;" | '''Low grade intraepithelial neoplasia(squamous cell carcinoma)'''
| style="padding: 7px 7px; background: #F5F5DC;" |6, 11
| style="padding: 7px 7px; background: #F5F5DC;" |16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52, 54, 61, 70, 72, 74
|-
| style="padding: 7px 7px; background: #DCDCDC;" | '''High grade intraepithelial neoplasia(squamous cell carcinoma)'''
| style="padding: 7px 7px; background: #F5F5DC;" |16, 18
| style="padding: 7px 7px; background: #F5F5DC;" |6, 11, 31, 33, 34, 35, 39, 42, 44, 45, 51, 52, 56, 58, 66, 67
|-
|-
|}
|}

Revision as of 18:29, 7 October 2016

Sexually transmitted diseases Main Page

Human papillomavirus Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Human papillomavirus from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Surgery

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Human papillomavirus classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Human papillomavirus classification

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Human papillomavirus classification

CDC on Human papillomavirus classification

Human papillomavirus classification in the news

Blogs on Human papillomavirus classification

Directions to Hospitals Treating Human papillomavirus

Risk calculators and risk factors for Human papillomavirus classification

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Classification

Based on tissue involvement, human papillomavirus (HPV) is classified in to 3 main groups:

  • Cutaneous
  • Anogenital
  • Other Mucosal surfaces

Currently, 210 different types of HPV have been discovered and the number keeps increasing.[1][2] Clinical manifestations depend on which HPV type involve which anatomic area.

Clinical presentation Frequently found Less Frequently found
Common wart 1, 2, 4 4, 26, 27, 29, 41, 57, 63, 65, 77, 117, 125, 128, 129, 130, 131, 132, 133, 148, 149
Plantar wart 1, 2 26, 27, 29, 41, 57, 63, 65, 77, 117, 125, 128, 129, 130, 131, 132, 133, 148, 149
Flat and intermediate warts 3, 10 26, 27, 28, 38, 41, 49, 75, 76, 126
Common warts of meat, poultry, and fish handlers 2, 7 1, 3, 4, 10, 28
Epidermodysplasia verruciformis 3, 5, 8 9 , 12 , 14 , 15 , 17 , 19–25 , 36–38 , 47 , 49 , 50
Low grade intraepithelial neoplasia(squamous cell carcinoma) 6, 11 16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52, 54, 61, 70, 72, 74
High grade intraepithelial neoplasia(squamous cell carcinoma) 16, 18 6, 11, 31, 33, 34, 35, 39, 42, 44, 45, 51, 52, 56, 58, 66, 67





References

  1. ↑ "Reference clones at International HPV Reference Center".
  2. ↑ Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM (2010). "Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments". Virology. 401 (1): 70–9. doi:10.1016/j.virol.2010.02.002. PMC 3400342. PMID 20206957.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Human_papillomavirus_classification&oldid=1259194"